Lantheus Holdings, Inc. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
Lantheus Holdings, Inc. (LNTH) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of $65.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-02-26
- Lantheus Holdings, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was $65.90M, a 27.19% decline from fiscal 2024.
- Lantheus Holdings, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was $90.51M, a 4.88% increase from fiscal 2023.
- Lantheus Holdings, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was $86.30M, a 1438.01% increase from fiscal 2022.
- Lantheus Holdings, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was $5.61M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | $65.90M 10-K · filed 2026-02-26 |
| 2024-12-31 | $90.51M 10-K · filed 2026-02-26 |
| 2023-12-31 | $86.30M 10-K · filed 2026-02-26 |
| 2022-12-31 | $5.61M 10-K · filed 2025-02-26 |
| 2021-12-31 | -$15.76M 10-K · filed 2024-02-22 |
| 2020-12-31 | -$2.41M 10-K · filed 2023-02-23 |
| 2019-12-31 | $6.01M 10-K · filed 2022-02-24 |
| 2018-12-31 | $10.40M 10-K · filed 2021-02-25 |
| 2017-12-31 | $13.87M 10-K · filed 2020-02-25 |
| 2016-12-31 | $9.90M 10-K · filed 2019-02-20 |
| 2015-12-31 | -$4.12M 10-K · filed 2018-02-26 |
| 2014-12-31 | -$828.00K 10-K · filed 2017-02-23 |
| 2013-12-31 | -$21.18M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |